NeuroKaire transforms brain health by integrating precision medicine into psychiatry and neurology. Using a simple blood test, NeuroKaire analyzes patient-derived neurons, genetics, and medical history to identify optimal antidepressant treatments, eliminating trial-and-error prescribing. This approach significantly improves patient outcomes, reduces side effects, and accelerates targeted CNS drug discovery, providing pharmaceutical companies with innovative tools to advance drug development.